Aflibercept monotherapy or bevacizumab first for diabetic macular edema
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD). Methods: Retrospective observational study of the number of intravitreal injections of bevacizumab and treatment switch in pa...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Saila: | Indian Journal of Ophthalmology |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=14;spage=260;epage=264;aulast=Hostovsky |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|